<DOC>
	<DOCNO>NCT01432535</DOCNO>
	<brief_summary>This study compare pharmacokinetics single dose peginterferon alfa-2b ( Sylatron® ) healthy participant participant moderate severe impairment kidney function .</brief_summary>
	<brief_title>Pharmacokinetics Peginterferon Alfa-2b Participants With Moderate Severe Renal Impairment ( P05655 )</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Body Mass Index ( BMI ) 19 40 kg/m^2 , inclusive Moderate renal impairment severe renal impairment and/or endstage renal disease ( ESRD ) may require hemodialysis normal renal function Free clinically significant disease ( except relate renal disease comorbid condition ) require physician 's care would interfere study Females reproductive potential must use medically accepted method contraception three month prior screen must agree use accepted contraceptive method two month follow study Males must agree use medically accept method contraception trial 3 month study Pregnant , intend become pregnant , breastfeed Surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug History infectious disease within 4 week prior study drug administration affect ability participate study Positive hepatitis B surface antigen , and/or human immunodeficiency virus ( HIV ) antibody . Healthy participant positive hepatitis C antibodies Previously receive PegIntron® , Sylatron® , and/or Pegasys More 10 cigarette equivalent tobacco use per day History malignancy Hypothyroidism hyperthyroidism History depression require treatment psychotherapy medication History suicidality risk selfharm harm others History autoimmune disorder require medical therapy Immune mediate renal insufficiency Removal kidney ( healthy participant ) function renal transplant ( participant renal impairment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>